Search

Your search keyword '"Weinberg, Jeffrey S"' showing total 418 results

Search Constraints

Start Over You searched for: Author "Weinberg, Jeffrey S" Remove constraint Author: "Weinberg, Jeffrey S"
418 results on '"Weinberg, Jeffrey S"'

Search Results

1. Response of treatment-naive brain metastases to stereotactic radiosurgery

2. Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial

5. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes

8. Accelerated Magnetic Resonance Thermometry in Presence of Uncertainties

10. Proposed definition of competencies for surgical neuro-oncology training

14. Response of Treatment-Naive Brain Metastases to Stereotactic Radiosurgery

16. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

18. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience

21. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial

24. Supplementary Figure 4 from Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial

25. Supplementary Figure 3 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

26. Supplementary Figure 4 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

27. Supplementary Figure 1 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

28. Supplementary Figure 6 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

29. Supplementary Figure 5 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

30. Supplementary Figure 2 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

31. Supplementary Figure Legends from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

32. Supplementary Figure 3 from Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial

33. Data from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

34. Retrospective Analysis of Imaging Characteristics of Tectal Gliomas

35. Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

36. Visualization and Planning of Neurosurgical Interventions with Straight Access

45. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

47. Treatment for Brain Metastases:ASCO-SNO-ASTRO Guideline

49. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

Catalog

Books, media, physical & digital resources